Our Recommendations
New Publications
- NTDs Part 1: Buruli Ulcer, Chagas, Leishmaniasis (2024)
- Leishmaniasis (2023)
- Standard operating procedures for supply chain management of health products for neglected tropical diseases amenable to preventive chemotherapy (2022)
- WHO guideline for the treatment of visceral leishmaniasis in HIV co-infected patients in East Africa and South-East Asia (2022)
- Cutaneous Leishmaniasis: Urgent need to develop more effective and user-friendly point-of-care diagnostic tools (2022)
Filter
32
Featured
Recommendations
2
New Publications
2
Language
Document type
Studies & Reports
11
Guidelines
7
Fact sheets
6
Strategic & Response Plan
3
No document type
3
Training Material
1
Resource Platforms
1
Countries / Regions
Global
15
Latin America and the Carribbean
9
Middle East and North Africa
4
Sudan
4
Asia
3
Brazil
3
Ethiopia
3
South Sudan
3
India
3
Kenya
2
South–East Asia Region
2
East and Southern Africa
2
Bangladesh
2
Greece
2
Somalia
2
Nepal
1
Colombia
1
Mexico
1
Turkey
1
China
1
Syria
1
Iran
1
Albania
1
Senegal
1
Morocco
1
Africa
1
Jordan
1
Saudi Arabia
1
West and Central Africa
1
Western and Central Europe
1
Paraguay
1
North America
1
Tunisia
1
Southern Africa
1
Lebanon
1
Eastern Europe
1
Georgia
1
Iraq
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Toolboxes
Leishmaniasis
17
Studies & Reports
11
Vector control
5
Statistics & Facts
4
NTDs General
4
Overview, Studies & Reports
4
Clinical Aspects & Diagnostics
3
Opportunistic Infections
1
Pharmacy
1
Essential Medicines
1
Clinical Aspects & Diagnostics
1
Statistics & Facts
1
Statistics & Facts
1
Information & Education Material (IEC)
1
There are 3 main forms of leishmaniases: visceral (the most serious form because it is almost always fatal without treatment), cutaneous (the most common, usually causing skin ulcers), and mucocutaneous (affecting mouth, nose and throat).
Leishmaniasis is caused by protozoan parasites which are tra...
Leishmaniasis is an important worldwide disease with a
zoonotic potential that presenting visceral and cutaneous
clinical forms. The domestic dog is seen as the main reservoir of Leishmania spp. and for this reason, it is the target of
the control program in some countries. The health professiona...
Leishmaniasis is a parasitic disease that is found in parts of the tropics, subtropics, and southern Europe. Leishmaniasis is caused by infection with Leishmania parasites, which are spread by the bite of infected sand flies. There are several different forms of leishmaniasis in people. The most com...
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv...
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with...
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from ...
In 2007, the Sixtieth World Health Assembly adopted resolution WHA60.13 on control of leishmaniasis, urging Member States, among other actions:
to strengthen prevention, active detection and treatment of cases of both cutaneous and visceral leishmaniasis in order to decrease the disease burde...
In the Region of the Americas, the leishmaniases are a group of diseases caused by various species of Leishmania, which cause a set of clinical syndromes in infected humans that can involve the skin, mucosa, and visceral organs. The spectrum of clinical disease is varied and depends on the interacti...
La leishmaniasis es un problema creciente de salud pública en el contextomundial. En Colombia, la situación es de alarma debido al incremento de casos de leishmaniasis cutánea que se viene registrando desde 2003 y el cambio en el patrón epidemiológico dado por la aparición de nuevos focos, el ...
